Global Alpha 1 Antitrypsin Deficiency Treatment Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Alpha 1 Antitrypsin Deficiency Treatment market will register a 5.3%% CAGR in terms of revenue, the global market size will reach $ 1383.8 million by 2025, from $ 1125.8 million in 2019. In particular, this report presents the global revenue market share of key companies in Alpha 1 Antitrypsin Deficiency Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Alpha 1 Antitrypsin Deficiency Treatment market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Alpha 1 Antitrypsin Deficiency Treatment, covering the supply chain analysis, impact assessment to the Alpha 1 Antitrypsin Deficiency Treatment market size growth rate in several scenarios, and the measures to be undertaken by Alpha 1 Antitrypsin Deficiency Treatment companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Augmentation Therapy
Bronchodilators
Corticosteroids
Oxygen Therapy
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Hospitals
Specialty Clinics
Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Takeda
Baxter
Grifols
Teva Pharmaceutical Industries
AstraZeneca
GlaxoSmithKline
Boehringer Ingelheim
CSL Behring
Kamada Ltd
Arrowhead Research Corporation
Chiesi Pharmaceuticals
ProBioGen
LFB Biomedicaments
Applied Genetic Technologies
Biogen
ProMetic Life Sciences
Baxalta
Abeona Therapeutics
Curaxys
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Alpha 1 Antitrypsin Deficiency Treatment market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Alpha 1 Antitrypsin Deficiency Treatment market by identifying its various subsegments.
Focuses on the key global Alpha 1 Antitrypsin Deficiency Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Alpha 1 Antitrypsin Deficiency Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Alpha 1 Antitrypsin Deficiency Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size 2015-2025
2.1.2 Alpha 1 Antitrypsin Deficiency Treatment Market Size CAGR by Region
2.2 Alpha 1 Antitrypsin Deficiency Treatment Segment by Type
2.2.1 Augmentation Therapy
2.2.2 Augmentation Therapy
2.2.3 Corticosteroids
2.2.4 Oxygen Therapy
2.3 Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type
2.3.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Type (2015-2020)
2.3.2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate by Type (2015-2020)
2.4 Alpha 1 Antitrypsin Deficiency Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Pharmacies
2.5 Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application
2.5.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Application (2015-2020)
2.5.2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate by Application (2015-2020)
3 Global Alpha 1 Antitrypsin Deficiency Treatment by Players
3.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Players
3.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by Players (2018-2020)
3.1.2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Players (2018-2020)
3.2 Global Alpha 1 Antitrypsin Deficiency Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Alpha 1 Antitrypsin Deficiency Treatment by Regions
4.1 Alpha 1 Antitrypsin Deficiency Treatment Market Size by Regions
4.2 Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth
4.3 APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth
4.4 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth
4.5 Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth
5 Americas
5.1 Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size by Countries
5.2 Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type
5.3 Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size by Regions
6.2 APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type
6.3 APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Alpha 1 Antitrypsin Deficiency Treatment by Countries
7.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type
7.3 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment by Countries
8.2 Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type
8.3 Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Alpha 1 Antitrypsin Deficiency Treatment Market Forecast
10.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Forecast (2021-2025)
10.2 Global Alpha 1 Antitrypsin Deficiency Treatment Forecast by Regions
10.2.1 Global Alpha 1 Antitrypsin Deficiency Treatment Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Alpha 1 Antitrypsin Deficiency Treatment Forecast by Type
10.8 Global Alpha 1 Antitrypsin Deficiency Treatment Forecast by Application
11 Key Players Analysis
11.1 Pfizer
11.1.1 Company Details
11.1.2 Alpha 1 Antitrypsin Deficiency Treatment Product Offered
11.1.3 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Pfizer News
11.2 Takeda
11.2.1 Company Details
11.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Offered
11.2.3 Takeda Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Takeda News
11.3 Baxter
11.3.1 Company Details
11.3.2 Alpha 1 Antitrypsin Deficiency Treatment Product Offered
11.3.3 Baxter Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Baxter News
11.4 Grifols
11.4.1 Company Details
11.4.2 Alpha 1 Antitrypsin Deficiency Treatment Product Offered
11.4.3 Grifols Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Grifols News
11.5 Teva Pharmaceutical Industries
11.5.1 Company Details
11.5.2 Alpha 1 Antitrypsin Deficiency Treatment Product Offered
11.5.3 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Teva Pharmaceutical Industries News
11.6 AstraZeneca
11.6.1 Company Details
11.6.2 Alpha 1 Antitrypsin Deficiency Treatment Product Offered
11.6.3 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 AstraZeneca News
11.7 GlaxoSmithKline
11.7.1 Company Details
11.7.2 Alpha 1 Antitrypsin Deficiency Treatment Product Offered
11.7.3 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 GlaxoSmithKline News
11.8 Boehringer Ingelheim
11.8.1 Company Details
11.8.2 Alpha 1 Antitrypsin Deficiency Treatment Product Offered
11.8.3 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Boehringer Ingelheim News
11.9 CSL Behring
11.9.1 Company Details
11.9.2 Alpha 1 Antitrypsin Deficiency Treatment Product Offered
11.9.3 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 CSL Behring News
11.10 Kamada Ltd
11.10.1 Company Details
11.10.2 Alpha 1 Antitrypsin Deficiency Treatment Product Offered
11.10.3 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Kamada Ltd News
11.11 Arrowhead Research Corporation
11.12 Chiesi Pharmaceuticals
11.13 ProBioGen
11.14 LFB Biomedicaments
11.15 Applied Genetic Technologies
11.16 Biogen
11.17 ProMetic Life Sciences
11.18 Baxalta
11.19 Abeona Therapeutics
11.20 Curaxys
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Alpha 1 Antitrypsin Deficiency Treatment Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Augmentation Therapy
Table 5. Major Players of Bronchodilators
Table 6. Major Players of Corticosteroids
Table 7. Major Players of Oxygen Therapy
Table 8. Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type (2014-2019) ($ Millions)
Table 9. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Type (2015-2020)
Table 10. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application (2015-2020) ($ Millions)
Table 11. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Application (2015-2020)
Table 12. Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Players (2018-2020) ($ Millions)
Table 13. Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Players (2018-2020)
Table 14. Global Alpha 1 Antitrypsin Deficiency Treatment Key Players Head office and Products Offered
Table 15. Alpha 1 Antitrypsin Deficiency Treatment Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by Regions 2015-2020 ($ Millions)
Table 19. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Regions 2015-2020
Table 20. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size by Countries (2015-2020) ($ Millions)
Table 21. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Countries (2015-2020)
Table 22. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type (2015-2020) ($ Millions)
Table 23. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Type (2015-2020)
Table 24. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application (2015-2020) ($ Millions)
Table 25. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Application (2015-2020)
Table 26. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size by Regions (2015-2020) ($ Millions)
Table 27. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Regions (2015-2020)
Table 28. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type (2015-2020) ($ Millions)
Table 29. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Type (2015-2020)
Table 30. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application (2015-2020) ($ Millions)
Table 31. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Application (2015-2020)
Table 32. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by Countries (2015-2020) ($ Millions)
Table 33. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Countries (2015-2020)
Table 34. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type (2015-2020) ($ Millions)
Table 35. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Type (2015-2020)
Table 36. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application (2015-2020) ($ Millions)
Table 37. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Application (2015-2020)
Table 38. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size by Countries (2015-2020) ($ Millions)
Table 39. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type (2015-2020) ($ Millions)
Table 41. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Type (2015-2020)
Table 42. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application (2015-2020) ($ Millions)
Table 43. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Application (2015-2020)
Table 44. Key and Potential Regions of Alpha 1 Antitrypsin Deficiency Treatment
Table 45. Key Application and Potential Industries of Alpha 1 Antitrypsin Deficiency Treatment
Table 46. Key Challenges of Alpha 1 Antitrypsin Deficiency Treatment
Table 47. Key Trends of Alpha 1 Antitrypsin Deficiency Treatment
Table 48. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 49. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share Forecast by Regions
Table 50. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Forecast by Type (2021-2025) ($ Millions)
Table 51. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share Forecast by Type (2021-2025)
Table 52. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Forecast by Application (2021-2025) ($ Millions)
Table 53. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share Forecast by Application (2021-2025)
Table 54. Pfizer Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 55. Pfizer Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 56. Pfizer Alpha 1 Antitrypsin Deficiency Treatment Revenue and Gross Margin (2018-2020E)
Table 57. Pfizer Main Business
Table 58. Pfizer Latest Developments
Table 59. Takeda Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 60. Takeda Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 61. Takeda Main Business
Table 62. Takeda Alpha 1 Antitrypsin Deficiency Treatment Revenue and Gross Margin (2018-2020E)
Table 63. Takeda Latest Developments
Table 64. Baxter Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 65. Baxter Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 66. Baxter Main Business
Table 67. Baxter Alpha 1 Antitrypsin Deficiency Treatment Revenue and Gross Margin (2018-2020E)
Table 68. Baxter Latest Developments
Table 69. Grifols Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 70. Grifols Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 71. Grifols Main Business
Table 72. Grifols Alpha 1 Antitrypsin Deficiency Treatment Revenue and Gross Margin (2018-2020E)
Table 73. Grifols Latest Developments
Table 74. Teva Pharmaceutical Industries Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 75. Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 76. Teva Pharmaceutical Industries Main Business
Table 77. Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Revenue and Gross Margin (2018-2020E)
Table 78. Teva Pharmaceutical Industries Latest Developments
Table 79. AstraZeneca Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 80. AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 81. AstraZeneca Main Business
Table 82. AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Revenue and Gross Margin (2018-2020E)
Table 83. AstraZeneca Latest Developments
Table 84. GlaxoSmithKline Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 85. GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 86. GlaxoSmithKline Main Business
Table 87. GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Revenue and Gross Margin (2018-2020E)
Table 88. GlaxoSmithKline Latest Developments
Table 89. Boehringer Ingelheim Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 90. Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 91. Boehringer Ingelheim Main Business
Table 92. Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Revenue and Gross Margin (2018-2020E)
Table 93. Boehringer Ingelheim Latest Developments
Table 94. CSL Behring Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 95. CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 96. CSL Behring Main Business
Table 97. CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Revenue and Gross Margin (2018-2020E)
Table 98. CSL Behring Latest Developments
Table 99. Kamada Ltd Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 100. Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Product Offered
Table 101. Kamada Ltd Main Business
Table 102. Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Revenue and Gross Margin (2018-2020E)
Table 103. Kamada Ltd Latest Developments
Table 104. Arrowhead Research Corporation Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 105. Chiesi Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 106. ProBioGen Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 107. LFB Biomedicaments Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 108. Applied Genetic Technologies Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 109. Biogen Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 110. ProMetic Life Sciences Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 111. Baxalta Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 112. Abeona Therapeutics Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
Table 113. Curaxys Details, Company Total Revenue (in $ million), Head Office, Alpha 1 Antitrypsin Deficiency Treatment Major Market Areas and Its Competitors
List of Figures
Figure 1. Alpha 1 Antitrypsin Deficiency Treatment Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Type (2015-2020)
Figure 5. Global Augmentation Therapy Market Size Growth Rate
Figure 6. Global Bronchodilators Market Size Growth Rate
Figure 7. Global Corticosteroids Market Size Growth Rate
Figure 8. Global Oxygen Therapy Market Size Growth Rate
Figure 9. Alpha 1 Antitrypsin Deficiency Treatment in Hospitals
Figure 10. Global Alpha 1 Antitrypsin Deficiency Treatment Market: Hospitals (2015-2020) ($ Millions)
Figure 11. Alpha 1 Antitrypsin Deficiency Treatment in Specialty Clinics
Figure 12. Global Alpha 1 Antitrypsin Deficiency Treatment Market: Specialty Clinics (2015-2020) ($ Millions)
Figure 13. Alpha 1 Antitrypsin Deficiency Treatment in Pharmacies
Figure 14. Global Alpha 1 Antitrypsin Deficiency Treatment Market: Pharmacies (2015-2020) ($ Millions)
Figure 15. Global Pharmacies YoY Growth ($ Millions)
Figure 16. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Application in 2019
Figure 17. Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Regions 2015-2020
Figure 18. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size 2015-2020 ($ Millions)
Figure 19. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size 2015-2020 ($ Millions)
Figure 20. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size 2015-2020 ($ Millions)
Figure 21. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size 2015-2020 ($ Millions)
Figure 22. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Countries in 2019
Figure 23. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Type in 2019
Figure 24. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Application in 2019
Figure 25. United States Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 26. Canada Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 27. Mexico Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 28. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Regions in 2019
Figure 29. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Type in 2019
Figure 30. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Application in 2019
Figure 31. China Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 32. Japan Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 33. Korea Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 34. Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 35. India Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 36. Australia Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 37. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Countries in 2019
Figure 38. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Type in 2019
Figure 39. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Application in 2019
Figure 40. Germany Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 41. France Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 42. UK Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 43. Italy Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 44. Russia Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 45. Spain Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 46. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Countries in 2019
Figure 47. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Type in 2019
Figure 48. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size Market Share by Application in 2019
Figure 49. Egypt Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 50. South Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 51. Israel Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 52. Turkey Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 53. GCC Countries Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 54. Global Alpha 1 Antitrypsin Deficiency Treatment arket Size Forecast (2021-2025) ($ Millions)
Figure 55. Americas Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 56. APAC Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 57. Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 58. Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 59. United States Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 60. Canada Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 61. Mexico Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 62. Brazil Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 63. China Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 64. Japan Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 65. Korea Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 66. Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 67. India Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 68. Australia Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 69. Germany Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 70. France Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 71. UK Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 72. Italy Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 73. Russia Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 74. Spain Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 75. Egypt Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 76. South Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 77. Israel Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 78. Turkey Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Figure 79. GCC Countries Alpha 1 Antitrypsin Deficiency Treatment Market Size 2021-2025 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets